TherapeuticsMD (TXMD) Reports Q4 Loss of $0.10/Share
Tweet
Share
E-mailGet Alerts TXMD Hot Sheet
Join SI Premium – FREE
TherapeuticsMD (NYSE: TXMD) reported Q4 EPS of ($0.10), versus ($0.06) reported last year. Revenue for the quarter came in at $4.26 million, versus $2.86 million reported last year.
For earnings history and earnings-related data on TherapeuticsMD (TXMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
- Southland Holdings (SLND) Misses Q2 EPS by 122c
- Logistic Properties of the Americas (LPA) Reports Q2 results
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
